For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place ...

The recent decision to merge Genentech’s two cancer departments was made for “scientific reasons,” executives explained to ...

AstraZeneca's Imfinzi was used before and after surgery in a clinical trial of patients with muscle-invasive bladder cancer — ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

It’s unclear if the layoffs are connected to Genentech’s closure of its cancer immunology research department, which Fierce Biotech reported earlier this month would include some layoffs.

Earlier this month, Genentech told Fierce Biotech it would close its cancer immunology research department located in South San Francisco, with the specific research functions destined to be ...

(KRON) — Biotech firm Genentech is laying off nearly 100 employees at its South San Francisco headquarters, according to a WARN notice from the California Employment Development Department (EDD).

The US Food and Drug Administration (FDA) has approved Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs), the first and ...

Related: Drug firm taps Genentech, Amgen execs as key leaders set departures Why this longtime biotech company is cutting another swath of jobs Related: Why this longtime biotech company is ...

For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place where researchers have developed new therapies in-house and published ...